This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Osteoarthritis

Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study

Sponsored by Primus Pharmaceuticals

About this trial

Last updated 10 years ago

Study ID

Primus Protocol #OAPS

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
30 to 85 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 19 years ago

What is this trial about?

safety, efficacy and acceptability of Flavocoxid

What are the participation requirements?

Yes

Inclusion Criteria